Anpario (LON:ANP - Get Free Report)'s stock had its "house stock" rating reaffirmed by investment analysts at Shore Capital Group in a research report issued to clients and investors on Monday,Digital Look reports.
Separately, Canaccord Genuity Group raised Anpario to a "buy" rating and lifted their target price for the company from GBX 457 to GBX 570 in a research report on Thursday, April 2nd. One analyst has rated the stock with a Buy rating, According to MarketBeat, the company has an average rating of "Buy" and a consensus price target of GBX 570.
View Our Latest Stock Analysis on Anpario
Anpario Trading Up 2.3%
Shares of ANP stock opened at GBX 496 on Monday. The firm has a market capitalization of £84.05 million, a P/E ratio of 13.07 and a beta of 0.99. The stock's fifty day moving average is GBX 489.68 and its two-hundred day moving average is GBX 494.84. Anpario has a fifty-two week low of GBX 370 and a fifty-two week high of GBX 580. The company has a debt-to-equity ratio of 0.60, a quick ratio of 5.16 and a current ratio of 4.50.
Anpario Company Profile
(
Get Free Report)
Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Anpario, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anpario wasn't on the list.
While Anpario currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.